Australia markets open in 7 hours 10 minutes

ImmuPharma PLC (25I.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0200-0.0010 (-4.76%)
As of 04:08PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
69.959
0
118.35
126.667
Operating expenses
Research development
1,808
2,023
3,650
2,373
Selling general and administrative
703.248
846.571
1,011
1,765
Total operating expenses
2,728
3,029
5,278
5,716
Operating income or loss
-2,658
-3,029
-5,160
-5,589
Interest expense
-173.698
2.036
124.063
230.828
Income before tax
-3,764
-4,456
-8,941
-7,246
Income tax expense
-772.569
-648.902
-766.814
-386.248
Income from continuing operations
-2,991
-3,807
-8,174
-6,860
Net income
-2,991
-3,807
-8,174
-6,860
Net income available to common shareholders
-2,991
-3,807
-8,174
-6,860
Basic EPS
-0.01
-0.01
-0.03
-0.03
Diluted EPS
-0.01
-0.01
-0.03
-0.03
Basic average shares
327,122
302,913
251,164
200,176
Diluted average shares
327,122
302,913
251,164
200,176